Business
Spectracure Says Study Shows Significant PSA Reduction In Prostate Cancer Patients
Spectracure Says Study Shows Significant PSA Reduction In Prostate Cancer Patients
About this update from Spectracure Ab
SpectraCure AB (publ) OMXSTO:SPEC:STUDY SHOWS SIGNIFICANT PSA REDUCTION IN PROSTATE CANCER PATIENTSPSA LEVELS DROP TO 0.0-0.5 NG/ML AFTER TREATMENT